FDA Approves New Treatment for HoFH

No Comments

On Dec 24th, 2012 Aegerion Pharmaceuticals, Inc. announced that the U.S. Food & Drug Administration (FDA) approved new treatment for Homozygous Familial Hypercholesterolemia (HoFH) called JUXTAPID™ (lomitapide). The capsules are intended as an adjunct to a low-fat diet and other cholesterol-lowering … Read More →

Learn About Cascade Screening and FH


In September, the Family Heart Foundation participated in the “New Strategies in Public Health Genomics” conference at the Centers for Disease Control (CDC).  Experts and key stakeholders, including advocates, community leaders and clinicians, came together to discuss evidence-based genomic … Read More →

1 44 45 46